. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
.
.
.
share on google plus google-plus
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
.